| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.004 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |